Your session is about to expire
← Back to Search
Check Yourself - Oncology for Risk Reduction Behavior (AHEAD Trial)
Phase 1
Waitlist Available
Led By Tyler G Ketterl, MD, MS
Research Sponsored by Seattle Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
AHEAD Trial Summary
This study is evaluating whether a new electronic health assessment tool may be useful for adolescents with cancer.
AHEAD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Determine the acceptability of eHA tool in AYA patients undergoing cancer directed therapy.
Determine the feasibility of eHA tool in AYA patients undergoing cancer directed therapy.
Determine the usability of eHA tool in AYA patients undergoing cancer directed therapy.
AHEAD Trial Design
1Treatment groups
Experimental Treatment
Group I: eHA ScreeningExperimental Treatment1 Intervention
Patients receiving eHA screening tool.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Check Yourself - Oncology
2021
Completed Phase 1
~30
Find a Location
Who is running the clinical trial?
Seattle Children's HospitalLead Sponsor
303 Previous Clinical Trials
5,216,795 Total Patients Enrolled
Tickit Health SolutionsUNKNOWN
Tyler G Ketterl, MD, MSPrincipal InvestigatorSeattle Children's Research Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger